Pines Wealth Management LLC Purchases Shares of 2,352 Zoetis Inc. (NYSE:ZTS)

Pines Wealth Management LLC purchased a new position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,352 shares of the company's stock, valued at approximately $384,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Mizuho Securities USA LLC grew its holdings in shares of Zoetis by 13,726.9% during the third quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company's stock worth $950,524,000 after buying an additional 4,829,815 shares in the last quarter. International Assets Investment Management LLC boosted its position in Zoetis by 41,235.7% during the third quarter. International Assets Investment Management LLC now owns 939,974 shares of the company's stock worth $183,652,000 after acquiring an additional 937,700 shares during the last quarter. Marshall Wace LLP grew its stake in Zoetis by 7,608.6% during the 2nd quarter. Marshall Wace LLP now owns 835,684 shares of the company's stock valued at $144,874,000 after acquiring an additional 824,843 shares in the last quarter. Nordea Investment Management AB raised its holdings in Zoetis by 38.3% in the 4th quarter. Nordea Investment Management AB now owns 2,065,514 shares of the company's stock valued at $336,266,000 after acquiring an additional 572,511 shares during the last quarter. Finally, Holocene Advisors LP purchased a new position in Zoetis in the 3rd quarter worth approximately $110,809,000. 92.80% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on ZTS. Stifel Nicolaus dropped their price target on Zoetis from $210.00 to $180.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th. Leerink Partnrs upgraded Zoetis to a "strong-buy" rating in a report on Monday, December 2nd. JPMorgan Chase & Co. lifted their price target on Zoetis from $225.00 to $230.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Leerink Partners initiated coverage on shares of Zoetis in a research report on Monday, December 2nd. They set an "outperform" rating and a $215.00 price target on the stock. Finally, UBS Group initiated coverage on shares of Zoetis in a research report on Monday, December 9th. They set a "neutral" rating and a $196.00 price objective for the company. One research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $211.89.

Zoetis Trading Up 1.4 %

ZTS stock traded up $2.31 during mid-day trading on Thursday, hitting $169.48. 1,953,175 shares of the company were exchanged, compared to its average volume of 2,594,107. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $200.53. The firm has a market capitalization of $76.47 billion, a P/E ratio of 31.87, a PEG ratio of 2.51 and a beta of 0.89. The business has a fifty day simple moving average of $171.31 and a 200-day simple moving average of $180.16. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, topping analysts' consensus estimates of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The firm had revenue of $2.40 billion during the quarter, compared to analysts' expectations of $2.29 billion. During the same quarter last year, the company posted $1.36 EPS. The firm's quarterly revenue was up 11.6% on a year-over-year basis. On average, equities research analysts predict that Zoetis Inc. will post 5.91 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.18%. This is a boost from Zoetis's previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Tuesday, January 21st. Zoetis's payout ratio is presently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.